Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Prepaid Assets: 2022-2024

Historic Prepaid Assets for Axsome Therapeutics (AXSM) over the last 3 years, with Dec 2024 value amounting to $12.0 million.

  • Axsome Therapeutics' Prepaid Assets rose 47.56% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year increase of 47.56%. This contributed to the annual value of $12.0 million for FY2024, which is 47.60% up from last year.
  • As of FY2024, Axsome Therapeutics' Prepaid Assets stood at $12.0 million, which was up 47.60% from $8.1 million recorded in FY2023.
  • In the past 5 years, Axsome Therapeutics' Prepaid Assets registered a high of $12.0 million during FY2024, and its lowest value of $2.8 million during FY2022.
  • Over the past 3 years, Axsome Therapeutics' median Prepaid Assets value was $8.1 million (recorded in 2023), while the average stood at $7.6 million.
  • Data for Axsome Therapeutics' Prepaid Assets shows a peak YoY skyrocketed of 191.80% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Axsome Therapeutics' Prepaid Assets stood at $2.8 million in 2022, then soared by 191.80% to $8.1 million in 2023, then skyrocketed by 47.60% to $12.0 million in 2024.